The Power of Malaria Vaccine Trials Using Controlled Human Malaria Infection.

about

Changes in total and differential leukocyte counts during the clinically silent liver phase in a controlled human malaria infection in malaria-naïve Dutch volunteers.Mosquito Infectivity and Parasitemia after Controlled Human Malaria Infection

P2860

Q44169768-3ACD3C75-5328-47E5-9BE0-611661974820 Q56379066-C6B06011-C274-4FA2-B868-438B34AC8DC4

P2860

The Power of Malaria Vaccine Trials Using Controlled Human Malaria Infection.

Item

http://www.wikidata.org/entity/Q36247418

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

The Power of Malaria Vaccine Trials Using Controlled Human Malaria Infection.

@ast

The Power of Malaria Vaccine Trials Using Controlled Human Malaria Infection.

@en

type

Item

label

The Power of Malaria Vaccine Trials Using Controlled Human Malaria Infection.

@ast

The Power of Malaria Vaccine Trials Using Controlled Human Malaria Infection.

@en

prefLabel

The Power of Malaria Vaccine Trials Using Controlled Human Malaria Infection.

@ast

The Power of Malaria Vaccine Trials Using Controlled Human Malaria Infection.

@en

P1476

The Power of Malaria Vaccine Trials Using Controlled Human Malaria Infection.

@en

P2093

Cornelus C Hermsen

http://www.w3.org/2001/XMLSchema#string

Sake J de Vlas

http://www.w3.org/2001/XMLSchema#string

P2860

A review of malaria vaccine clinical projects based on the WHO rainbow table

Comparison of clinical and parasitological data from controlled human malaria infection trials

Design, recruitment, and microbiological considerations in human challenge studies.

Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data.

Clinical outcome of experimental human malaria induced by Plasmodium falciparum-infected mosquitoes.

Phase 1/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02A.

Clinical manifestations of Plasmodium falciparum malaria experimentally induced by mosquito challenge.

Memory B-cell and antibody responses induced by Plasmodium falciparum sporozoite immunization.

Optimising Controlled Human Malaria Infection Studies Using Cryopreserved P. falciparum Parasites Administered by Needle and Syringe.

Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection.

P304

e1005255

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PCBI.1005255

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Luc E Coffeng

Robert W Sauerwein

P577

2017-01-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28081133

http://www.w3.org/2001/XMLSchema#string

P921

malaria

P932

5230743

http://www.w3.org/2001/XMLSchema#string

The Power of Malaria Vaccine Trials Using Controlled Human Malaria Infection.

about

P2860

P2860

The Power of Malaria Vaccine Trials Using Controlled Human Malaria Infection.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932